Do You Have Asthma?

Volunteer for a pregnancy study on asthma from the comfort of your home.

MotherToBaby is currently enrolling pregnant women in an observational study to learn more about asthma and its treatment during pregnancy. If you join our study, our team will monitor your pregnancy and your baby’s development for a period of time after birth. Our research is by observation only—we will not ask you to take or change any medications. Plus, you can participate from the comfort of your home.

“Help us improve the ability for pregnant women and their health provider to make safe treatments decisions by joining our Asthma & Pregnancy study!”

— Christina Chambers, PhD, MPH, MotherToBaby Pregnancy Studies

Better Info about Pregnancy Health Starts with You

We’re seeking two groups of participants. If you belong to either of these groups, you could qualify to join us:

Women who are currently taking FASENRA® (benralizumab), NUCALA® (mepolizumab) or DUPIXENT® (dupilumab) during pregnancy.

Women who have asthma and have not taken the above medications during pregnancy.

All of our studies include:

1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby. Some studies may have additional interviews.

Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.

Join Our Study

Your information is confidential.

MotherToBaby Pregnancy Studies

UC San Diego School of Medicine

Questions? Call 866.626.6847 | Text 855.999.3525 | Email or Chat at

Disclaimer: MotherToBaby Fact Sheets are meant for general information purposes and should not replace the advice of your health care provider. MotherToBaby is a service of the non-profit Organization of Teratology Information Specialists (OTIS). OTIS/MotherToBaby recognizes that not all people identify as “men” or “women.” When using the term “mother,” we mean the source of the egg and/or uterus and by “father,” we mean the source of the sperm, regardless of the person’s gender identity. Copyright by OTIS, May 23, 2020.